Drugs Made In America Acquisition II Corp.

DMIIR

NASDAQFinancial ServicesFinancial - Conglomerates

Open in GoAI

Previous close

$0.091

$0.00 · 0.00%

Aug 20, 4:00 PM ET

Historical prices · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

53/100

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

Deep Value

Momentum

Weakening

Sentiment

Mixed

Risk resilience

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.

Industry: Financial - Conglomerates
Sector: Financial Services
Headquarters: US
CEO: Roger Bendelac
Listed since: Dec 4, 2025
Employees: 2

Market position

Day range

Current $0.091

$0.09$0.10

52-week range

Current $0.091

$0.09$0.10

Open: $0.0965
Previous close: $0.091
Volume: 108; 0.01× average
Average volume: 21.46K; Average daily volume
Market cap: 6.33M USD
Beta: 1.96; Market reference 1
50-day average: $0.083; +9.63% above average
200-day average: $0.1018; -10.64% below average

Financials

Financial statements

Income trends

Operating income

−1.3M USD-757.18%

Net income

4.19M USD+4.34M USD

Metric (USD)	FY2025	FY2024
Selling, general, and administrative	1.3M USD	151.72K USD
Operating expenses	1.3M USD	151.72K USD
Interest income	4.93M USD	—
Operating income	−1.3M USD	−151.72K USD
Net income	4.19M USD	−151.72K USD